Glenn M. Engelmann, Senior Counsel, McDermott Will & Emery to Speak at KC’s Understanding FDA's Guidance on Direct-To-Consumer Television Advertisements
Glenn M. Engelmann, Senior Counsel, McDermott Will & Emery to Speak at KC’s Understanding the Food and Drug Administration’s Guidance on Direct-To-Consumer Television Advertisements Live Webcast
New York, NY, September 24, 2012 --(PR.com)-- The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Glenn M. Engelmann, Senior Counsel, McDermott Will & Emery will speak at the Knowledge Congress’ webcast entitled: “Understanding the Food and Drug Administration’s Guidance on Direct-To-Consumer Television Advertisements.” This event is scheduled for Thursday, January 31, 2013 from 12:00pm – 2:00pm (ET).
For further details, please visit:
http://www.knowledgecongress.org/event_2012_Food_and_Drug.html
About Glenn Engelmann
Glenn Engelmann is Senior Counsel in the law firm of McDermott Will & Emery LLP and is based in the Firm’s Washington, D.C. office. In advising clients, he leverages his 25 years of experience managing complex legal and regulatory matters in the pharmaceutical industry. As the Vice Chair of McDermott’s multi-disciplinary global Life Sciences Industry Group, Glenn is integral to the ongoing development of the growth of this important part of the firm’s practice. Prior to joining McDermott, Glenn served as a member of Astra Zeneca’s executive leadership team responsible for managing the U.S. business. In this role, he provided advice and support to company leadership in addressing a wide range of legal and regulatory matters including defending multiple Federal and State investigations and patent challenges. For the last two and a half years of his tenure , he was responsible for the legal support for the global sales and marketing organization as well. In 2012, Glenn was selected as a Life Science Star by LMG Life Sciences. He is a member of the D.C. bar and is also past chair of the PhRMA Law Section Executive Committee.
About McDermott Will & Emery
McDermott Will & Emery (www.mwe.com) has one of the largest and most prestigious Health law practices in the world, counseling leading organizations in every major sector of the health and life sciences industry on legal, regulatory and business transaction issues. For the second consecutive year Chambers USA ranked the Firm's Health practice as the only Tier 1 Health Practice in the United States. The Firm’s Life Sciences Industry Group is also nationally ranked by Chambers USA, and this group of 135+ lawyers, patent agents and scientific advisors provides the full range of legal services required by life sciences companies, regardless of their stage of development.
Event Synopsis:
The Food and Drug Administration recently issued draft guidance to explain its approach to pre-dissemination review of direct-to-consumer (DTC) television advertisements. The draft guidance represents a significant change in FDA’s approach and attempts to provide detail on what steps advertisers should take and what enforcement steps, including civil and criminal penalties, may be expected.. If adopted, the Guidance will present significant compliance challenges for all companies in the industry.
Pharmaceutical companies and ad sponsors should have a complete understanding of FDA’s current thinking as reflected in this draft guidance to assess its potential impact on their business relations.
The Knowledge Group is assembling a panel of distinguished professionals and key regulators to help understand the complex issues related to the draft guidance and its impact on your firm and the broader market. The speakers will present their expert opinions in a two-hour Live Webcast.
About The Knowledge Group, LLC/The Knowledge Congress Live Webcast Series
The Knowledge Congress was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register to an event, please visit: www.knowledgecongress.org
For further details, please visit:
http://www.knowledgecongress.org/event_2012_Food_and_Drug.html
About Glenn Engelmann
Glenn Engelmann is Senior Counsel in the law firm of McDermott Will & Emery LLP and is based in the Firm’s Washington, D.C. office. In advising clients, he leverages his 25 years of experience managing complex legal and regulatory matters in the pharmaceutical industry. As the Vice Chair of McDermott’s multi-disciplinary global Life Sciences Industry Group, Glenn is integral to the ongoing development of the growth of this important part of the firm’s practice. Prior to joining McDermott, Glenn served as a member of Astra Zeneca’s executive leadership team responsible for managing the U.S. business. In this role, he provided advice and support to company leadership in addressing a wide range of legal and regulatory matters including defending multiple Federal and State investigations and patent challenges. For the last two and a half years of his tenure , he was responsible for the legal support for the global sales and marketing organization as well. In 2012, Glenn was selected as a Life Science Star by LMG Life Sciences. He is a member of the D.C. bar and is also past chair of the PhRMA Law Section Executive Committee.
About McDermott Will & Emery
McDermott Will & Emery (www.mwe.com) has one of the largest and most prestigious Health law practices in the world, counseling leading organizations in every major sector of the health and life sciences industry on legal, regulatory and business transaction issues. For the second consecutive year Chambers USA ranked the Firm's Health practice as the only Tier 1 Health Practice in the United States. The Firm’s Life Sciences Industry Group is also nationally ranked by Chambers USA, and this group of 135+ lawyers, patent agents and scientific advisors provides the full range of legal services required by life sciences companies, regardless of their stage of development.
Event Synopsis:
The Food and Drug Administration recently issued draft guidance to explain its approach to pre-dissemination review of direct-to-consumer (DTC) television advertisements. The draft guidance represents a significant change in FDA’s approach and attempts to provide detail on what steps advertisers should take and what enforcement steps, including civil and criminal penalties, may be expected.. If adopted, the Guidance will present significant compliance challenges for all companies in the industry.
Pharmaceutical companies and ad sponsors should have a complete understanding of FDA’s current thinking as reflected in this draft guidance to assess its potential impact on their business relations.
The Knowledge Group is assembling a panel of distinguished professionals and key regulators to help understand the complex issues related to the draft guidance and its impact on your firm and the broader market. The speakers will present their expert opinions in a two-hour Live Webcast.
About The Knowledge Group, LLC/The Knowledge Congress Live Webcast Series
The Knowledge Congress was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register to an event, please visit: www.knowledgecongress.org
Contact
The Knowledge Congress
Thomas LaPointe, Jr., Executive Director
1.800.578.4370
www.knowledgecongress.org
Therese Lumbao, Director
Account Management & Member Services
tlumbao@knowledgecongress.org
Thomas LaPointe, Jr., Executive Director
1.800.578.4370
www.knowledgecongress.org
Therese Lumbao, Director
Account Management & Member Services
tlumbao@knowledgecongress.org
Contact
Categories